Our | Products


Relotib





THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Erlotinib
PRESENTATION: 150 mg x 30 coated tablets and 100 mg x 30 coated tablets
INDICATION:

  • Non-Small Cell Lung Cancer
  • Pancreatic Cancer

COUNTRIES WHERE IT IS MARKETED:
Argentina Perú